Wang Liyang, Song Danjun, Wang Wentao, Li Chengquan, Zhou Yiming, Zheng Jiaping, Rao Shengxiang, Wang Xiaoying, Shao Guoliang, Cai Jiabin, Yang Shizhong, Dong Jiahong
School of Clinical Medicine, Tsinghua University, Beijing 100084, China.
Hepato-Pancreato-Biliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China.
Cancers (Basel). 2023 Mar 15;15(6):1784. doi: 10.3390/cancers15061784.
Background Currently, surgical decisions for hepatocellular carcinoma (HCC) resection are difficult and not sufficiently personalized. We aimed to develop and validate data driven prediction models to assist surgeons in selecting the optimal surgical procedure for patients. Methods Retrospective data from 361 HCC patients who underwent radical resection in two institutions were included. End-to-end deep learning models were built to automatically segment lesions from the arterial phase (AP) of preoperative dynamic contrast enhanced magnetic resonance imaging (DCE-MRI). Clinical baseline characteristics and radiomic features were rigorously screened. The effectiveness of radiomic features and radiomic-clinical features was also compared. Three ensemble learning models were proposed to perform the surgical procedure decision and the overall survival (OS) and recurrence-free survival (RFS) predictions after taking different solutions, respectively. Results SegFormer performed best in terms of automatic segmentation, achieving a Mean Intersection over Union (mIoU) of 0.8860. The five-fold cross-validation results showed that inputting radiomic-clinical features outperformed using only radiomic features. The proposed models all outperformed the other mainstream ensemble models. On the external test set, the area under the receiver operating characteristic curve (AUC) of the proposed decision model was 0.7731, and the performance of the prognostic prediction models was also relatively excellent. The application web server based on automatic lesion segmentation was deployed and is available online. Conclusions In this study, we developed and externally validated the surgical decision-making procedures and prognostic prediction models for HCC for the first time, and the results demonstrated relatively accurate predictions and strong generalizations, which are expected to help clinicians optimize surgical procedures.
背景 目前,肝细胞癌(HCC)切除术的手术决策困难且个性化程度不足。我们旨在开发并验证数据驱动的预测模型,以协助外科医生为患者选择最佳手术方案。方法 纳入了来自两个机构的361例行根治性切除术的HCC患者的回顾性数据。构建了端到端深度学习模型,以从术前动态对比增强磁共振成像(DCE-MRI)的动脉期(AP)自动分割病变。严格筛选临床基线特征和影像组学特征。还比较了影像组学特征和影像组学-临床特征的有效性。提出了三种集成学习模型,分别在采取不同解决方案后进行手术方案决策以及总生存(OS)和无复发生存(RFS)预测。结果 SegFormer在自动分割方面表现最佳,平均交并比(mIoU)达到0.8860。五折交叉验证结果表明,输入影像组学-临床特征的表现优于仅使用影像组学特征。所提出的模型均优于其他主流集成模型。在外部测试集上,所提出的决策模型的受试者操作特征曲线下面积(AUC)为0.7731,预后预测模型的性能也相对出色。基于病变自动分割的应用网络服务器已部署并可在线获取。结论 在本研究中,我们首次开发并在外部验证了HCC的手术决策程序和预后预测模型,结果显示预测相对准确且具有较强的泛化能力,有望帮助临床医生优化手术方案。